Torrent Pharmaceuticals slips on getting observations from USFDA for Dahej plant

08 Apr 2019 Evaluate

Torrent Pharmaceuticals is currently trading at Rs. 1803.05, down by 39.10 points or 2.12% from its previous closing of Rs. 1842.15 on the BSE.

The scrip opened at Rs. 1844.00 and has touched a high and low of Rs. 1852.40 and Rs. 1799.40 respectively. So far 6800 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1964.00 on 29-Mar-2019 and a 52 week low of Rs. 1282.00 on 25-May-2018.

Last one week high and low of the scrip stood at Rs. 1952.00 and Rs. 1799.40 respectively. The current market cap of the company is Rs. 30524.41 crore.

The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 19.01% and 9.74% respectively.

Torrent Pharmaceuticals has received certain observations from the US Food and Drug Administration (USFDA) for Dahej plant which are procedural in nature and the company is confident of addressing them satisfactorily. The audit at Dahej Plant of the company was carried out by USFDA in the month of March, 2019.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.


Torrent Pharma Share Price

3735.10 -22.35 (-0.59%)
17-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×